“Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?

The COVID-19 (coronavirus disease-2019) pandemic has presented unprecedented challenges to regulatory organizations, the biotech and pharmaceutical industry, and the publishing industry. This Translational Perspectives paper attempts to highlight some of the challenges and perils of moving extraordi...

Descripción completa

Detalles Bibliográficos
Autor principal: Van Norman, Gail A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
TRANSLATIONAL PERSPECTIVE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393415/
https://www.ncbi.nlm.nih.gov/pubmed/32760859
http://dx.doi.org/10.1016/j.jacbts.2020.06.001
_version_ 1783565040179216384
author Van Norman, Gail A.
author_facet Van Norman, Gail A.
author_sort Van Norman, Gail A.
collection PubMed
description The COVID-19 (coronavirus disease-2019) pandemic has presented unprecedented challenges to regulatory organizations, the biotech and pharmaceutical industry, and the publishing industry. This Translational Perspectives paper attempts to highlight some of the challenges and perils of moving extraordinarily fast in an effort to save human lives in the midst of a global pandemic. As with the development of all new therapeutic approaches, it will take time to assess the risks and benefits of developing new therapies at “warp speed”.
format Online
Article
Text
id pubmed-7393415
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73934152020-08-04 “Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly? Van Norman, Gail A. JACC Basic Transl Sci TRANSLATIONAL PERSPECTIVE The COVID-19 (coronavirus disease-2019) pandemic has presented unprecedented challenges to regulatory organizations, the biotech and pharmaceutical industry, and the publishing industry. This Translational Perspectives paper attempts to highlight some of the challenges and perils of moving extraordinarily fast in an effort to save human lives in the midst of a global pandemic. As with the development of all new therapeutic approaches, it will take time to assess the risks and benefits of developing new therapies at “warp speed”. Elsevier 2020-06-17 /pmc/articles/PMC7393415/ /pubmed/32760859 http://dx.doi.org/10.1016/j.jacbts.2020.06.001 Text en © 2020 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle TRANSLATIONAL PERSPECTIVE
Van Norman, Gail A.
“Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
title “Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
title_full “Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
title_fullStr “Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
title_full_unstemmed “Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
title_short “Warp Speed” Operations in the COVID-19 Pandemic: Moving Too Quickly?
title_sort “warp speed” operations in the covid-19 pandemic: moving too quickly?
topic TRANSLATIONAL PERSPECTIVE
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393415/
https://www.ncbi.nlm.nih.gov/pubmed/32760859
http://dx.doi.org/10.1016/j.jacbts.2020.06.001
work_keys_str_mv AT vannormangaila warpspeedoperationsinthecovid19pandemicmovingtooquickly

Ejemplares similares